|
J Biol Chem, Vol. 273, Issue 11, 6171-6176, March 13, 1998
Biochemical Analysis of Potential Sites for Protein 4.1-mediated
Anchoring of the Spectrin-Actin Skeleton to the Erythrocyte
Membrane
Ryan F.
Workman and
Philip S.
Low
From the Department of Chemistry, Purdue University,
West Lafayette, Indiana 47907-1393
Erythrocyte protein 4.1 has been hypothesized to
link the spectrin-actin junctional complex directly to the cytoplasmic
domain of glycophorin C, but this bridging function has never been
directly demonstrated. Because an alternative protein-mediated bridge
between the junctional complex and the cytoplasmic domain of band 3 is also plausible, we have undertaken to characterize the membrane sites
to which protein 4.1 can anchor the spectrin and actin skeleton. We
demonstrate that proteolytic removal of the cytoplasmic domain of band
3 has minimal effect on the ability of protein 4.1 to promote
125I-labeled spectrin and actin binding to
KI-stripped erythrocyte membrane vesicles. We also show that
quantitative blockade of all band 3 sites with either monoclonal or
polyclonal antibodies to band 3 is equally ineffective in preventing
protein 4.1-mediated association of spectrin and actin with the
membrane. In contrast, obstruction of protein 4.1 binding to its
docking site on the cytoplasmic pole of glycophorin C is demonstrated
to reduce the same protein 4.1 bridging function by ~85%. We
conclude from these data that (i) glycophorin C contributes the primary
anchoring site of the protein 4.1-mediated bridge to the spectrin-actin skeleton; (ii) band 3 is incapable of serving the same function; and
(iii) additional minor protein 4.1 bridging sites may exist on the
human erythrocyte membrane.
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. Rank, R. Sutton, V. Marshall, R. J. Lundie, J. Caddy, T. Romeo, K. Fernandez, M. P. McCormack, B. M. Cooke, S. J. Foote, et al.
Novel roles for erythroid Ankyrin-1 revealed through an ENU-induced null mouse mutant
Blood,
April 2, 2009;
113(14):
3352 - 3362.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. L. Peters, R. A. Swearingen, S. G. Andersen, B. Gwynn, A. J. Lambert, R. Li, S. E. Lux, and G. A. Churchill
Identification of quantitative trait loci that modify the severity of hereditary spherocytosis in wan, a new mouse model of band-3 deficiency
Blood,
April 15, 2004;
103(8):
3233 - 3240.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Biederer and T. C. Sudhof
CASK and Protein 4.1 Support F-actin Nucleation on Neurexins
J. Biol. Chem.,
December 14, 2001;
276(51):
47869 - 47876.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Gascard, G. Lee, L. Coulombel, I. Auffray, M. Lum, M. Parra, J.G. Conboy, N. Mohandas, and J.A. Chasis
Characterization of Multiple Isoforms of Protein 4.1R Expressed During Erythroid Terminal Differentiation
Blood,
December 1, 1998;
92(11):
4404 - 4414.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|